U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390422) titled 'Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease' on Jan. 28.
Brief Summary: This study is designed to evaluate the efficacy, safety, and mechanisms of ReCET procedure in patients with T2DM and its effect on MASLD.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
T2DM (Type 2 Diabetes Mellitus)
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic Syndrome (MetS)
Intervention:
PROCEDURE: ReCET treatment
The ReCET procedure utilizes the ReCET catheter to deliver non-thermal pulsed electric field to the duodenum to induce cell regeneration. The ...